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Abstract Tetanus toxin acts by blocking the release of glycine
from inhibitory neurones within the spinal cord. An initial stage
in the toxin’s action is binding to acceptors on the nerve surface
and polysialogangliosides are a component of these acceptor
moieties. Using site-directed mutagenesis, we identify tyrosine-
1290 of tetanus toxin as a key residue that is involved in
ganglioside binding. This residue, which is located at the centre of
a shallow pocket on the L-trefoil domain of the tetanus Hc
fragment, is also shown to play a key role in the functional
binding of tetanus toxin to spinal cord neurones leading to the
inhibition of neurotransmitter release. ß 2001 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Tetanus toxin (TeNT) and the seven botulinum toxin sero-
types (BoNTs) make up the clostridial neurotoxin family
which act by blocking neurotransmitter release [1,2]. The
BoNTs act primarily at the neuromuscular junction which
results in the widespread £accid paralysis characteristic of
botulism. TeNT, in contrast, while initially binding to the
peripheral nervous system, is retrogradely transported to the
central nervous system where it blocks glycine release from
inhibitory interneurones. It is this di¡erent tra⁄cking of
TeNT that give rise to the spastic paralysis observed with
tetanus intoxication and distinguishes it from the BoNTs.
TeNT and the BoNTs are structurally similar, they have
30^40% sequence homology and each neurotoxin consists of
a heavy chain (100 kDa) and a light chain (50 kDa) linked by
a disulphide bridge [1]. The neurotoxins exert their biological
e¡ects on their target nerve cell via similar multi-step mecha-
nisms [1,2]. Following a binding step, in which the neurotox-
ins bind to ecto-acceptors on the presynaptic nerve surface [3],
the toxins are internalised and translocated within the nerve
ending. Once inside the nerve terminal, each toxin mediates its
e¡ect via a highly speci¢c zinc-dependent endopeptidase ac-
tivity directed at small proteins (either VAMP/synaptobrevin,
SNAP-25 or syntaxin) involved in the fusion and release of
synaptic vesicles [2]. Domains within the C-terminal 50 kDa
fragment (Hc fragment) of each neurotoxin heavy chain play
the primary role in acceptor binding [3,4] while the N-terminal
50 kDa of the heavy chain is involved in translocation of the
enzymically active light chain to within the nerve terminal [5].
The isolated Hc fragment of TeNT retains the high a⁄nity
(Kd6 1039 M) neuronal binding properties of the holotoxin
and has been used in a variety of studies aimed at character-
ising the nature of the acceptor [6^8]. A number of reports
have demonstrated that TeNT binds to the polysialic ganglio-
sides, GD1b and GT1b, but not the monosialic acid ganglio-
side GM1 (reviewed in [1]). Recently it has been demonstrated
that ganglioside biosynthesis in primary spinal cord neurones
is essential for their intoxication with TeNT [9]. While poly-
sialogangliosides are clearly implicated as a component of the
neurotoxin acceptor, the protease sensitivity of TeNT binding
to both synaptosomes and neuronal cells also suggests the
involvement of a protein component [10] and a two-compo-
nent acceptor model has been proposed [1,11]. A 15 kDa
glycoprotein, which is present in both toxin-sensitive PC12
cells and spinal cord neurones, has been shown to interact
with the C-terminal domain of TeNT Hc fragment by cross-
linking experiments and has been proposed as the protein
acceptor component for TeNT [12,13].
Crystal structures of TeNT Hc [14], BoNT/A [15] and
BoNT/B [16] reveal two distinct domains within the Hc frag-
ment of each toxin: a lectin-like jelly-roll domain (residues
865^1110 of TeNT) and a L-trefoil domain (residues 1125^
1315) (Fig. 1). Previous studies on TeNT have demonstrated
that only the L-trefoil domain is required for cell and ganglio-
side binding and photoa⁄nity labelling studies with ganglio-
side GT1b have implicated H1293 in the vicinity of the gan-
glioside binding site [17]. In a recent study which characterised
the binding properties of TeNT Hc mutants, it was shown that
a H1293 mutant in which the ganglioside binding was greatly
reduced still demonstrated retrograde transport within motor
neurones [18]. These authors concluded that other regions
within the C-terminal domain are involved in cell binding
leading to retrograde transport.
In the present study, we have sought to clarify the regions
of TeNT Hc involved in ganglioside activity with respect to
the biological action of the neurotoxin. Site-directed mutants
have been constructed within the C-terminal region of TeNT
Hc and characterised with respect to their binding to synaptic
membranes, gangliosides and spinal cord neurones. We iden-
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tify a tyrosine residue which plays a critical role in both the
binding of TeNT to gangliosides and its functional binding to
spinal cord neurones leading to the inhibition of calcium-de-
pendent glycine release.
2. Materials and methods
2.1. Production and puri¢cation of TeNT Hc fragment mutants
A fully synthetic TeNT Hc gene was synthesised using a codon bias
optimised for expression in Escherichia coli. Restriction sites BamHI
and XbaI were incorporated at the 5P and 3P ends, respectively, to
allow subcloning into expression vectors. Site-directed mutants were
constructed by PCR or splice overlap PCR using mutagenic primers
[19] and their sequences con¢rmed. Hc-encoding fragments were sub-
cloned into the vector pMAL-c2x (New England Biolabs) and ex-
pressed as maltose binding protein (MBP) fusions in the host strain
BL21 (Novagen). A single colony was inoculated into 200 ml of Ter-
ri¢c Broth (24 g/l yeast extract, 12 g/l tryptone, 9.4 g/l KH2PO4, 2.2 g/l
K2HPO4, pH 7.2) supplemented with 100 Wg/ml ampicillin and 0.5%
(w/v) glucose and grown overnight at 30‡C in a shaking incubator.
Cultures were diluted 1:6 with fresh medium and grown to an OD600
of approximately 2.0 at 30‡C. IPTG was added (500 WM) and cultures
grown for 2 h at 25‡C. Cell pellets were resuspended in 20 mM Tris^
HCl pH 7.4, 500 mM NaCl, 1 mM EDTA (binding bu¡er) and lysed
by sonication. Cell debris was removed by centrifugation at 27 000Ug
and the supernatant £uid applied to a 5 ml amylose resin (NEB)
column equilibrated in the binding bu¡er. After washing with binding
bu¡er, the fusion protein was eluted with binding bu¡er supplemented
with 10 mM maltose. MBP was removed from fusion proteins by
treatment with factor Xa protease (1 U/mg) at 20‡C for 18 h in the
elution bu¡er. TeNT Hc fragments were puri¢ed by anion exchange
(Mono-Q) chromatography and then dialysed against 20 mM HEPES
pH 7.4 containing 200 mM NaCl.
2.2. Radiolabelling of TeNT
TeNT, puri¢ed by ion exchange chromatography [20], was dialysed
against 0.1 M borate bu¡er pH 8.5 and then 100 Wl containing 300 Wg
TeNT was reacted with dried Bolton and Hunter reagent (37 MBq;
Amersham Pharmacia Biotech) for 15 min on ice with gentle agita-
tion. Unreacted reagent was separated from the 125I-labelled TeNT by
gel ¢ltration on Sephadex G25 (PD10 column, Pharmacia) equilibrat-
ed in 0.05 M HEPES, 0.2 M NaCl pH 7.4.
2.3. Binding to rat brain synaptic membranes
Rat cerebrocortical synaptosomes were puri¢ed as described previ-
ously [4] and diluted in 0.05 M HEPES pH 7.4 bu¡er to a ¢nal
concentration of 2 mg/ml synaptosomal protein. Binding assays
were performed in either 0.05 M HEPES pH 7.4 bu¡er containing
0.6% bovine serum albumin (BSA) (HEPES binding bu¡er) or Hanks’
pH 7.4 bu¡er containing 0.6% BSA (Hanks’ binding bu¡er). Binding
assay incubations (0.2 ml) contained a ¢nal concentration of 2 nM
125I-labelled TeNT and varying concentrations of TeNT Hc frag-
ments. Assays performed in HEPES binding bu¡er were initiated by
the addition of synaptosomal membranes to a ¢nal concentration of
1 Wg/ml synaptosomal protein and those in Hanks’ bu¡er by the
addition of 100 Wg/ml synaptosomal protein. Assays were incubated
for 2 h at 2‡C and then washed twice with 1 ml aliquots of the
respective binding bu¡er and radioactivity in the synaptosome pellet
determined [4].
2.4. Binding to gangliosides
Gangliosides GT1b or GM1 (s 98% pure; Research Biochemicals
International) were diluted to 20 Wg/ml in methanol, added to micro-
titre plates (50 Wl/well) and allowed to dry for 16 h at 22‡C. Plates
were then blocked with HEPES binding bu¡er for 1 h at 37‡C before
being washed six times with phosphate-bu¡ered saline, pH 7.4. Bind-
ing assay mixtures containing 2 nM 125I-labelled TeNT and various
concentrations of unlabelled TeNT Hc fragments in HEPES binding
bu¡er were added (50 Wl/well) and incubated for 1 h at 22‡C. Plates
were then washed with 2U150 Wl of HEPES binding bu¡er and the
radioactivity bound to plate wells determined.
2.5. Measurement of glycine release from embryonic spinal cord
neurones
Embryonic spinal cord (eSC) neurones were prepared and main-
tained as described previously [21]. For competition experiments,
21 day old eSC neurones were incubated with 150 pM TeNT with
or without TeNT Hc fragments for 30 min at 37‡C in medium con-
taining 5% donor horse serum. The toxin was removed and the cells
washed twice with medium and incubated for a further 20 h at 37‡C.
The eSC neurones were then loaded with [3H]glycine prior to the
determination of basal and potassium-stimulated release of the trans-
mitter as described [21].
3. Results and discussion
3.1. E¡ect of TeNT Hc mutants on binding to brain
synaptosomal membranes
The acceptor binding e⁄ciencies of mutants were evaluated
initially in competition experiments with 125I-labelled TeNT to
rat brain synaptosomes. Previous studies have shown that at
low ionic strength, TeNT binds to a neuraminidase-sensitive,
ganglioside-like acceptor on synaptic membranes which is
largely insensitive to proteases, while in physiological bu¡ers,
TeNT binds at lower density to acceptors which are sensitive
to both neuraminidase and proteases which suggests the in-
volvement of a protein acceptor component [10]. Binding of
TeNT Hc mutants to synaptosomes was therefore evaluated
under both bu¡er conditions. Competition experiments were
performed using native and mutant Hc fragments both as
MBP fusions and after removal of MBP. No di¡erences in
their binding characteristics were observed.
A number of studies have illustrated the importance of the
C-terminal region of the L-trefoil domain of the TeNT Hc
fragment, so site-directed mutants were initially conducted
in this region. Table 1 summarises the e¡ects of various site-
directed mutants on acceptor binding properties of TeNT Hc
Fig. 1. TeNT Hc structure. Three-dimensional structure of TeNT
Hc fragment showing the L-trefoil and lectin-like domains. The posi-
tions of tyrosine-1290, located within helix-5 [20], and glutamate-
1310, located within the C-terminal domain, are also shown.
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mutants to brain synaptic membranes. Several alanine substi-
tutions were made in the region 1305^1310, close to the C-
terminus, which has been reported to be critical to acceptor
binding [3]. Of these, E1310A was found to signi¢cantly re-
duce the binding. This was more marked when binding assays
were performed under physiological conditions in Hanks’
bu¡er (Fig. 2A). Other mutants made in this C-terminal re-
gion had little or no e¡ect on binding. Inspection of the three-
dimensional structure of TeNT Hc fragment reveals that the
C-terminal eight residues border one side of a shallow surface
pocket which is de¢ned on other sides by strands L17, L22 and
loops preceding these strands [14]. Alanine mutants made to
these regions were found to have little of no e¡ect on synap-
tosome binding. Since, of the mutants analysed, only E1310A
signi¢cantly reduced the binding of TeNT Hc to synaptic
membranes, more conservative mutations were made to this
and the adjacent charged residue (D1309) to further analyse
their role in binding. Neither the E1310Q nor the D1309N
mutation was found to have any e¡ect on synaptosome bind-
ing (Table 1a). Collectively, these data argue against a direct
role for C-terminal residues 1305^1310 in acceptor binding.
Previous studies employing photoa⁄nity labelling have im-
plicated H1293 in ganglioside binding, and mutagenesis of this
residue signi¢cantly reduced binding to gangliosides in solid-
Table 1
Binding of TeNT Hc mutants to synaptosomal membranes
Hc mutant Binding relative to native TeNT
Hc (mean values þ S.D.; n = 4)
HEPES bu¡er Hanks’ bu¡er
(a) C-terminal pocket mutants
(i) Alanine mutations
E1310CA 35 þ 13% 9.5 þ 2.9%
D1309CA as native as native
F1305CA as native as native
W1303CA as native 35 þ 8%
R1168CA as native 32 þ 4%
Y1170CA as native as native
(ii) Conservative mutations
E1310CQ as native as native
D1309CN as native as native
E1310CQ; D1309CN as native as native
R1168CK as native as native
(b) Helix-5 region mutants
(i) Alanine mutations
Y1290CA 7.7 þ 1.5% 6 1%
N1292CA as native as native
K1295CA as native as native
K1297CA as native as native
(ii) Conservative mutations of
Y1290
Y1290CF 42 þ 11% 54 þ 3.5%
Y1290CS 6 3% 6 1%
Fig. 2. Binding of TeNT Hc mutants to synaptic membranes and
gangliosides. Competitive binding experiments were performed using
a ¢xed concentration of 125I-labelled TeNT (2 nM) and various con-
centrations of competing ligands. A: Binding was carried out in
Hanks’ bu¡er pH 7.4 containing 0.6% BSA to rat brain synaptic
membranes. Competing ligands were: native TeNT Hc (b), K1295A
(F), E1310A (R), Y1290A (S). B: Binding was carried out in 0.05
M HEPES bu¡er pH 7.4 containing 0.6% BSA to rat brain synaptic
membranes. Competing ligands were: native TeNT Hc (b), Y1290F
(F), Y1290A (R), Y1290S (S). C: Binding to ganglioside GT1b in
0.05 M HEPES bu¡er pH 7.4 containing 0.6% BSA. Competing li-
gands were: native TeNT Hc (b), Y1290F (F), Y1290A (R),
Y1290S (S). The relative binding to GM1 ganglioside using TeNT
Hc as competing ligand is also shown (E). Each graph represents
data from one experiment in quadruplicate with S.D. In each case,
quantitatively similar results were obtained in two further experi-
ments.
C
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phase assays [17,18]. To investigate the role in acceptor bind-
ing of this region around helix-5 [14], which is located on the
opposite side of the L-trefoil domain to the C-terminus, fur-
ther point mutants were constructed in the vicinity of H1293
(Table 1b). Mutant Y1290A signi¢cantly reduced the binding
to synaptosome membranes in assays performed using low
ionic strength bu¡er at pH 7.4 (Fig. 2B) and in similar assays
performed in Hanks’ bu¡er, the binding of mutant Y1290A
was abolished (Fig. 2A). Further substitutions of Y1290 were
made to determine their e¡ects on the acceptor binding. Mu-
tant Y1290F showed approximately twofold reduced binding
to synaptic membranes compared to control TeNT Hc, while
in the case of Y1290S, binding was further reduced compared
to the Y1290A mutant (Fig. 2B). In some competition experi-
ments with Y1290S, the mutant appeared to increase the bind-
ing of 125I-labelled TeNT compared to the control. This e¡ect,
however, was not statistically signi¢cant.
To assess the structural integrity of the Y1290 TeNT Hc
mutants, circular dichroism (CD) spectroscopic analysis was
performed in the far UV region. No signi¢cant di¡erences in
the CD spectra of the three Y1290 mutants were observed
when compared to native TeNT Hc suggesting that little or
no perturbation of the three-dimensional structure had been
induced.
3.2. Ganglioside binding of the TeNT Hc Y1290 mutants
The reduction in synaptosome acceptor binding activity of
the Y1290 mutants in HEPES (0.05 M, pH 7.4) binding bu¡er
suggests a loss of ganglioside binding activity. To con¢rm this,
mutants were assessed in competitive binding assays with 125I-
labelled TeNT to solid-phase GT1b gangliosides and their
binding compared with native TeNT Hc (Fig. 2C). The bind-
ing of Y1290 mutants to ganglioside was similar to that ob-
served to synaptic membranes in the HEPES binding bu¡er.
The binding of Y1290A and Y1290F was reduced to
16.1 þ 2.9% and 38 þ 2% (S.D.; n = 4) of the control value
respectively. The binding of Y1290S was greatly reduced
(6 2% of the control value). No speci¢c binding of 125I-la-
belled TeNT was observed in control experiments when GM1
ganglioside was substituted for GT1b ganglioside.
The signi¢cant reductions in both GT1b ganglioside and
synaptosome binding observed with all Y1290 mutants sug-
gest a key role for this residue in binding to the ganglioside.
This residue is also highly conserved within the BoNTs of the
clostridial neurotoxin family which also appear to bind a gan-
glioside as a component of the cellular acceptor [1]. Recently,
a putative ganglioside binding site on the clostridial neuro-
toxins has be proposed by Ginalski et al. [22] using struc-
ture-based sequence alignment. Inspection of the TeNT Hc
structure shows that Y1290 is orientated towards the centre
of this shallow pocket which is located on the L-trefoil do-
main. In addition, H1293, which is also implicated in ganglio-
side binding [23], is located on the rim of this pocket. In a
study in which TeNT Hc structure was determined in the
presence of various sugar residues, lactose was found to
bind to the proposed ganglioside binding pocket and form a
hydrogen bond with the OH of Y1290 [23]. In summary, the
data presented provide direct evidence for the location of the
ganglioside binding pocket as proposed by Ginalski et al. [22]
and suggest that Y1290 plays a key role in binding to the
sugar.
3.3. E¡ect of mutants on the functional binding of TeNT to
spinal cord neurones
TeNT binds to a diverse population of acceptors on neuro-
nal tissue of which only a small proportion lead to the func-
tional internalisation of the neurotoxin and subsequent block-
ade of neurotransmitter release. Studies were therefore
undertaken using spinal cord neurones to determine whether
or not Y1290 plays a role in the functional acceptor binding
of TeNT as measured by its ability to block the calcium-
mediated release of glycine. Incubation of spinal cord neu-
rones with 150 pM TeNT inhibited 60^80% of the calcium-
mediated glycine release. In the presence of an excess of native
TeNT Hc as a competing ligand, the inhibitory e¡ects of
TeNT are reduced (Fig. 3). In similar experiments performed
with the Y1290A mutant no competition with TeNT was ob-
served which suggests that this mutation results in a loss of
binding to the functional acceptor for TeNT.
In overall conclusion, data presented in the present study
suggest a key role of Y1290 in the binding of TeNT to its
neuronal acceptor. This residue lies at the heart of a shallow
pocket on the L-trefoil domain of TeNT Hc proposed as a
putative acceptor binding site [22] and the data presented here
provide the ¢rst direct evidence for a role of this pocket in
ganglioside binding. Furthermore, Y1290 is also shown to
play a critical role in the binding of TeNT to its functional
acceptors on spinal cord neurones.
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